Fundraising FoxConcinnitygenetics
Edinburgh, GB · 1 known investors
Find your way into Concinnitygenetics
Sign up to see every warm intro you have to Concinnitygenetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Concinnitygenetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies. Spun out of the University of Edinburgh in 2023, it serves gene therapy developers in the biopharmaceutical industry.
Founders & leadership
Investors · 1
Eos Advisorylisted by Eos AdvisorySt Andrews
How we know: the VCSheet dataset · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- CONCINNITY GENETICS LTD
- Company number
- SC786187
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 17 Oct 2023
- Registered office
- C/O Cms Cameron Mckenna Nabarro Olswang Llp 4th Floor, Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2EN
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 16 Oct 2025 · next due 30 Oct 2026
Current officers · 4
- Jessica Charlotte Birt — director, appointed 17 Oct 2023
- Graeme Charles Fielder — director, appointed 18 Jul 2025
- Liam Mark Taylor — director, appointed 11 Jul 2025
- David Charles Venables — director, appointed 17 Apr 2024
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Concinnitygenetics do?
- Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies. Spun out of the University of Edinburgh in 2023, it serves gene therapy developers in the biopharmaceutical industry.
- Who founded Concinnitygenetics?
- Concinnitygenetics was founded by Jessica Birt, Matthew Dale.
- Who are Concinnitygenetics's investors?
- Concinnitygenetics's investors include Eos Advisory.
- Where is Concinnitygenetics headquartered?
- Concinnitygenetics is headquartered in Edinburgh, GB.